Regardless of the safety problems, this is the part which I don't understand.
When an annual flu vaccine is created, the makers estimate a probably of certain strains and target the vaccine towards that ensemble for the year.
In contrast, despite the obvious data coming out that the original Covid shots were for the 1st two strains, the newer Delta, Lambda (and who knows how many others) have already evaded it and that was in less than a span of a year. Thus, the vaccine makers need to create ... NEW vaccines, not offer boosters of the same ones.
And for seconds, from the p.o.v of insipid pro-vaxxers, if a vaccine is outwitted within a year then it's almost like developing a semi-annual cold/rhinovirus shot, something which everyone (not just medical professionals) already know, is impossible.
Ok, so are pro-vaxxers mentally retarded? Because I see these two guys ...
Let me explain how a non-Beavis & Butthead vaccine looks like ...
This idea is not coding for a moving target like the Coronavirus (which will then need to be changed every 4 to 6 months) but in protecting the lungs using a non-specific immune response.
Excerpt: "A team at the Indian Council of Medical Research (ICMR)’s National Institute for Research in Tuberculosis has investigated whether the Bacillus Calmette-Guérin (BCG) vaccine, traditionally used to inoculate against tuberculosis, could reduce Covid-induced inflammation in elderly people.
The ICMR team said a major concern about using the BCG vaccine for Covid-19 was “the possibility of the vaccination inducing highly proinflammatory responses and thus worsening infection or disease in otherwise asymptomatic or mild cases”.
To understand the effect of BCG vaccination and inflammation in relation to Covid-19, the researchers evaluated the jab in 82 healthy elderly individuals, aged between 60 and 80, living in coronavirus infection hotspots.
Why is the BCG vaccine being explored?
One of the most widely used vaccines in the world, BCG is known to offer effective and broad protection against various diseases – including respiratory ones – by inducing nonspecific immunity effects. The jab is being evaluated against Covid-19 in multiple studies worldwide.
Valerie Koeken is a postdoctoral researcher focusing on infectious diseases, tuberculosis and vaccination research at Radboud University Medical Centre in the Netherlands. Her team has been researching BCG’s potential for other infectious diseases for a number of years, and began looking into the vaccine’s nonspecific immune effect on Covid-19 when the pandemic struck.
“Our group, but also a lot of other groups throughout the world, and also in collaboration with hospitals, started doing these bigger trials to see if BCG indeed has an effect on protection from Covid,” Koeken says.
What have researchers found?
The ICMR team found that study participants vaccinated with BCG had significantly reduced blood levels of proinflammatory proteins called cytokines. These preliminary findings are significant; the lung damage associated with severe Covid-19 infection is caused by the production of high levels of cytokines, also known as a cytokine storm.
“One of the hypotheses here could be that BCG reduces the inflammatory status of a person,” Koeken says, “and that could help when these patients get Covid, so they don’t get the severe proinflammatory response.”
Older people often have less effective immune systems, leaving them at higher risk of severe illness from Covid-19. If the BCG jab is effective at curbing inflammation, it could help protect elderly individuals who are unable to access Covid-19 jabs from the worst effects of the disease.
An earlier study, conducted as part of the ACTIVATE trial evaluating BCG’s potential to prevent infections in the elderly, also found that BCG revaccination resulted in a 68% risk reduction for total Covid-19 diagnoses and could serve as a preventative measure against the virus. This data is yet to be peer-reviewed.
Koeken said it is “important to emphasize” that these are merely observational studies, and that the link between BCG and reduced Covid-19 inflammation is, at this stage, just a hypothesis."
Thanks for sharing, glad to hear that others are working on an effective vax. This is another reason NOT to take the current clot shots, if everyone takes them there will be no control group and no group of people who could serve as test subjects for other potentially more effective vaccines.
Some people want one. They have a right to seek the best course of action for their own interests. Surely there is no need, but there is a demand for such a thing nonetheless.
When an annual flu vaccine is created, the makers estimate a probably of certain strains and target the vaccine towards that ensemble for the year.
In contrast, despite the obvious data coming out that the original Covid shots were for the 1st two strains, the newer Delta, Lambda (and who knows how many others) have already evaded it and that was in less than a span of a year. Thus, the vaccine makers need to create ... NEW vaccines, not offer boosters of the same ones.
And for seconds, from the p.o.v of insipid pro-vaxxers, if a vaccine is outwitted within a year then it's almost like developing a semi-annual cold/rhinovirus shot, something which everyone (not just medical professionals) already know, is impossible.
Ok, so are pro-vaxxers mentally retarded? Because I see these two guys ...